The Secretion of Endothelin-1 by Microvascular Endothelial Cells from Human Benign Prostatic Hyperplasia is Inhibited by Vascular Endothelial Growth Factor

References

• Andersson, K.E. Chapple, C.R. and Hofner, K. (2002) "Future drugs for the treatment of benign prostatic hyperplasia", World, J Urol. 19, 436–442.
   Google Scholar
• Campbell, C.L. Savarese, D.M. Quesenberry, P.J. and Savarese, T.M. (1999) "Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: predominance of vascular endothelial growth factor", Int. J. Cancer 80, 868–874.
   Google Scholar
• Carducci, M.A. Padley, R.J. Breul, J., Vogelzang, N.J. Zonnenberg, B.A. Daliani, D.D. Schulman, C.C. Nabulsi, A.A. Humerickhouse, R.A. Weinberg, M.A. Schmitt, J.L. and Nelson, J.B. (2003) "Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial", J. Clin. Oncol. 21, 679–689.
   Google Scholar
• Dall'Era, M.A. Shih, S.J. Yang, J., Benik, S., Gandour-Edwards, R. and Evans, C.P. (2001) "Differential expression of angiogenic cytokines by cell lines and primary cultures of human prostate cancer", Prostate Cancer Prostatic Dis. 4, 106–111.
   Google Scholar
• Drexler, H. and Hornig, B. (1999) "Endothelial dysfunction in human disease", J. Mol. Cell. Cardiol. 31, 51–60.
   Google Scholar
• Ferrer, F.A. Miller, L.J. Andrawis, R.I. Kurtzman, S.H. Albertsen, P.C. Laudone, V.P. and Kreutzer, D.L. (1997) "Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells", J. Urol. 157, 2329–2333.
   Google Scholar
• Folkman, J. (1998) Editorial "Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence", Endocrinology 139, 441–442.
   Google Scholar
• Franck-Lissbrandt, I., Haggstrom, S., Damber, J.E. and Bergh, A. (1998) "Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats", Endocrinology 139, 451–456.
   Google Scholar
• Furchgott, R.F. and Vanhoutte, P.M. (1989) "Endothelium-derived relaxing and contracting factors", FASEB, J 3, 2007–2018.
   Google Scholar
• Gerritsen, M.E. (1987) "Functional heterogeneity of vascular endothelial cells", Biochem. Pharmacol. 36, 2701–2711.
   Google Scholar
• Granchi, S., Brocchi, S., Bonaccorsi, L., Baldi, E., Vinci, M.C. Forti, G., Serio, M. and Maggi, M. (2001) "Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens", Prostate 49, 267–277.
   Google Scholar
• Grant, E.S. Brown, T., Roach, A., Williams, B.C. and Habib, F.K. (1997) "In vitro expression of endothelin-1 (ET-1) and the ETA and ETB ET receptors by the prostatic epithelium and stroma", J. Clin. Endocrinol. Meta. 82, 508–513.
   Google Scholar
• Hahn, D., Simak, R., Steiner, G.E. Handisurya, A., Susani, M. and Marberger, M. (2000) "Expresssion of the VEGF-receptor flt-1 in benign, premalignant and malignant prostate tissues", J. Urol. 164, 506–510.
   Google Scholar
• Haggstrom, S., Bergh, A. and Damber, J.E. (2000) "Vascular endothelial growth factor content in metastasizing and nonmetastasizing dunning prostatic adenocarcinoma", Prostate 45, 42–50.
   Google Scholar
• Hrouda, D., Nicol, D.L. and Gardiner, R.A. (2003) "The role of angiogenesis in prostate development and the pathogenesis of prostate cancer", Urol. Res. 30, 347–355.
   Google Scholar
• Joseph, I.B. and Isaacs, J.T. (1998) "Macrophage role in the anti-prostate cancer response to one class of angiogenic agents", J. Natl Cancer Inst. 90, 1648–1653.
   Google Scholar
• Kopetz, E.S. Nelson, J.B. and Carducci, M.A. (2002) "Endothelin-1 as a target for therapeutic intervention in prostate cancer", Invest. New Drugs 20, 173–182.
   Google Scholar
• Krupski, T., Harding, M.A. Herce, M.E. Gulding, K.M. Stoler, M.H. and Theodorescu, D. (2001) "The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells", Growth Factors 18, 287–302.
   Google Scholar
• Latil, A., Bieche, I., Pesche, S., Valeri, A., Fournier, G., Cussenot, O. and Lidereau, R. (2000) "VEGF overexpression in clinically localized prostate tumors and neuropillin-1 overexpression in metastatic forms", Int. J. Cancer 89, 167–171.
   Google Scholar
• Lees, D.M. Pallikaros, Z. and Corder, R. (2000) "The p55 tumor necrosis factor receptor (CD120a) induces endothelin synthesis in endothelial and epithelial cells", Eur. J. Pharmacol. 390, 89–94.
   Google Scholar
• Lissbrant, I.F. Lissbrant, E., Damber, J.E. and Bergh, A. (2001) "Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer", Scand. J. Urol. Nephrol. 35, 437–452.
   Google Scholar
• Lowry, O.H. Rosebrough, N.J. Farr, A.L. and Randall, R.J. (1951) "Protein measurement with the folin phenol reagent", J. Biol. Chem. 193, 265–275.
   Google Scholar
• Mombouli, J.V. and Vanhoutte, P.M. (1999) "Endothelial dysfunction: from physiology to therapy", J. Mol. Cell. Cardiol. 31, 61–74.
   Google Scholar
• van Moorselaar, R.J. van Stratum, P., Borm, G., Debruyne, F.M. and Schalken, J.A. (1991) "Differential antiproliferative activities of alpha- and gamma-interferon and tumor necrosis factor alone or in combinations against two prostate cancer xenografts transplanted in nude mice", Prostate 18, 331–344.
   Google Scholar
• Nakajima, Y., DelliPizzi, A., Mallouh, C. andFerreri, N.R. (1995) "Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of human prostate cancer cell lines", Urol. Res. 23, 205–210.
   Google Scholar
• Nelson, J.B. Chan-Tack, K., Hedican, S.P. Magnuson, S.R. Opgenorth, T.J. Bova, G.S. and Simons, J.W. (1996) "Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer", Cancer Res. 56, 663–668.
   Google Scholar
• Nelson, J., Bagnato, A., Battistini, B. and Nisen, P. (2003a) "The endothelin axis: emerging role in cancer", Nat. Rev. Cancer 3, 110–116.
   Google Scholar
• Nelson, J.B. Nabulsi, A.A. Vogelzang, N.J. Breul, J., Zonnenberg, B.A. Daliani, D.D. Schulman, C.C. and Carducci, M.A. (2003b) "Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan", J. Urol. 169, 1143–1149.
   Google Scholar
• Pirtskhalaishvili, G. and Nelson, J.B. (2000) "Endothelium-derived factors as paracrine mediators of prostate cancer progression", Prostate 44, 77–87.
   Google Scholar
• Saita, Y., Yazawa, H., Koizumi, T., Morita, T., Tamura, T., Takenaka, T. and Honda, K. (1998) "Mitogenic activity of endothelin on human cultured prostatic smooth muscle cells", Eur. J. Pharmacol. 349, 123–128.
   Google Scholar
• Sordello, S., Bertrand, N. and Plouet, J. (1998) "Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens", Biochem. Biophys. Res. Commun. 251, 287–290.
   Google Scholar
• Stachon, A., Stegemann, H., Hohage, H., Rahn, K.H. and Schlatter, E. (1998) "Effects of diadenosine polyphosphates on the intracellular Ca2+ concentration in endothelial cells", Cell. Physiol. Biochem. 8, 175–184.
   Google Scholar
• Stachon, A., Schluter, T., Koller, M., Weisser, H. and Krieg, M. (2001) "Primary culture of microvascular endothelial cells from human benign prostatic hyperplasia", Prostate 48, 156–164.
   Google Scholar
• Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R. and Sorg, C. (1994) "Macrophages and angiogenesis", J. Leukoc. Biol. 55, 410–422.
   Google Scholar
• Thorin, E., Shatos, M.A. Shreeve, S.M. Walters, C.L. and Bevan, J.A. (1997) "Human vascular endothelium heterogeneity. A comparative study of cerebral and peripheral cultured vascular endothelial cells", Stroke 28, 375–381.
   Google Scholar
• Walden, P.D. Ittman, M., Monaco, M.E. and Lepor, H. (1998) "Endothelin-1 production and agonist activities in cultured prostate-derived cells: implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia", Prostate 34, 241–250.
   Google Scholar
• Walsh, K., Sriprasad, S., Hopster, D., Codd, J. and Mulvin, D. (2002) "Distribution of vascular endothelial growth factor (VEGF) in prostate disease", Prostate Cancer Prostatic Dis. 5, 119–122.
   Google Scholar
• Wang, Y.Z. and Wong, Y.C. (1998) "Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer", Prostate 35, 165–177.
   Google Scholar
• Wu-Wong, J.R. Chiou, W.J. Dickinson, R. and Opgenorth, T.J. (1997a) "Endothelin attenuates apoptosis in human smooth muscle cells", Biochem. J. 328, 733–737.
   Google Scholar
• Wu-Wong, J.R. Chiou, W.J. Saeed, B., Magnuson, S.R. Dayton, B.D. Ng, S.C. and Opgenorth, T.J. (1997b) "Endothelin receptor in benign prostatic hyperplastic cells. Binding and functional studies", Recept. Signal. Transduct. 7, 165–175.
   Google Scholar
• Zhao, X., van Steenbrugge, G.J. and Schroder, F.H. (1992) "Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor", Urol. Res. 20, 193–197.
   Google Scholar